CESTAT Mumbai Affirms Glucometers as Instruments for Chemical Analysis

Aadrikaa Legal Services (ALS) – IDT Tax I Arbitration I Litigation

Date: 24.06.2026

CESTAT Mumbai Affirms Glucometers as Instruments for Chemical Analysis

The Customs, Excise & Service Tax Appellate Tribunal (CESTAT) Mumbai recently delivered a significant judgment in the case of Life Scan Medical Devices India Pvt. Ltd., clarifying the customs classification of blood glucose monitoring systems (glucometers). This article provides a detailed overview of the dispute, the legal arguments, and the implications of the Tribunal’s decision.

Background of the Case

Life Scan Medical Devices India Pvt. Ltd., a Special Economic Zone (SEZ) importer, brought in ‘One Touch Select Simple Blood Glucose Monitoring System’ and ‘One Touch Select Plus Simple Blood Glucose Monitoring System.’ The company classified these products under Customs Tariff Item (CTI) 90278090 as ‘Instruments or Apparatus for chemical analysis,’ claiming a NIL Basic Customs Duty (BCD).

However, the Customs Department argued that the correct classification should be under CTI 90189099, which covers ‘Instruments and appliances used in medical, surgical, dental or veterinary sciences.’ This classification would attract a 5% BCD due to a specific customs notification.

Key Legal Arguments

Revenue’s Position

1. Specific Heading Preference: The department contended that CTI 90189099 is more specific for glucometers, as they are primarily used for medical diagnostics.
2. Interpretation of HSN Notes: The Revenue argued that the Harmonized System of Nomenclature (HSN) Explanatory Notes support classification under 9018.
3. Legislative Intent: The department cited Notification No. 50/2017-Customs, emphasizing the intent to classify such devices under 9018.

Importer’s Position

1. Precedent Cases: The importer relied on previous decisions, notably the Bombay High Court’s ruling in M/s. Ascentia Diabetes Care India Pvt. Ltd. and the CESTAT decision in Bayer Pharmaceuticals Pvt. Ltd., both favoring classification under 9027.
2. Supreme Court Dismissals: The importer highlighted that the Supreme Court had dismissed the department’s appeals against these precedents, reinforcing the legal position.
3. Scientific Function: The importer argued that glucometers perform chemical analysis of blood, fitting the description under 9027.

Tribunal’s Analysis and Findings

• Nature of Glucometers: The Tribunal examined the scientific function of glucometers, noting that they analyze blood samples through chemical reactions to determine glucose concentration. This analytical function aligns with the description under CTH 9027.
• Interpretation of Tariff Headings: The Tribunal emphasized that the mere use of an instrument in medicine does not automatically place it under 9018 if a more specific heading describing its function exists.
• Precedent and Consistency: The Tribunal cited consistent judicial decisions, including those upheld by the Supreme Court, supporting classification under 9027.

Final Decision

The CESTAT Mumbai concluded that glucometers should be classified under CTH 9027 as instruments for chemical analysis. The Tribunal dismissed the Revenue’s appeal, affirming the importer’s classification and the decision of the Commissioner (Appeals).

Implications of the Ruling

1. Clarity for Importers: The decision provides legal certainty for importers of blood glucose monitoring systems regarding customs classification and applicable duties.
2. Precedential Value: The ruling, backed by Supreme Court dismissals of departmental appeals, sets a strong precedent for similar cases.
3. Scientific Approach: The judgment underscores the importance of considering the scientific function of devices in tariff classification.

Conclusion

The CESTAT Mumbai’s ruling in favor of Life Scan Medical Devices India Pvt. Ltd. marks a pivotal moment in the classification of medical diagnostic devices. By focusing on the analytical function of glucometers and adhering to established legal precedents, the Tribunal has provided much-needed clarity for the industry and customs authorities alike.

Source: CESTAT Mumbai

Disclaimer

Handy Download:

Write to us at office@aadrikaalaw.com

Tel: +91-11-4999 2707 I +91-9999005379

www.aadrikaalaw.com